Journal of medical imaging (Bellingham, Wash.) · 2026
SoftSpot3D: prospective study of mobile 3D reconstruction for infants' cranial conditions.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wu Bo, Kocabalkanli Can, Aalamifar Fereshteh, Linguraru Marius George, Zhang Athena, Keating Robert Francis, Myers Angela, Blondin Mario, Hederick Mary Kathryn, Runyan Christopher Michael, Rogers Gary Francis, Seifabadi Reza
Аннотация
SIGNIFICANCE: Accurate identification of residual tumor during head and neck cancer surgery is essential for preventing local recurrences and improving patient outcomes, yet current methods for intraoperative margin assessment remain limited. Fluorescence lifetime imaging (FLIm), a label-free optical technique, has shown strong potential for distinguishing cancerous from noncancerous tissue in vivo. However, the effect of tissue resection on autofluorescence properties is not well defined, raising the question of whether diagnostic signatures establishedin vivo translate reliably to ex vivo specimens.
AIM: The aim is to characterize how fluorescence lifetime properties change between in vivo and ex vivo conditions across multiple head and neck anatomical sites and to assess how these changes affect diagnostic separability between cancerous and noncancerous tissue.
APPROACH: A custom fiber-based, point-scanning FLIm system with phasor-based analysis was used to characterize fluorescence lifetime features in vivo and ex vivo across oral tongue, base of the tongue, and palatine tonsil tissue from 75 patients undergoing oropharyngeal surgery. A separability index based on phasor distributions was used to quantify cancer versus noncancer contrast across multiple spectral channels.
RESULTS: Resection-induced changes in decay dynamics and fluorescence lifetime values varied by anatomy: oral tongue and tonsil showed reduced contrast ex vivo, whereas the base of tongue demonstrated improved separation after excision. The base of the tongue showed a higher separability index ex vivo (0.43 versus 0.15 in vivo), whereas oral tongue and tonsil maintained superior contrast in vivo (0.27 versus 0.18 and 0.46 versus 0.28, respectively).
CONCLUSIONS: Surgical resection substantially alters autofluorescence signatures in an anatomy-dependent manner, emphasizing the need to train and validate diagnostic algorithms independently for in vivo surgical guidance and ex vivo pathology assessment.
AIM: The aim is to characterize how fluorescence lifetime properties change between in vivo and ex vivo conditions across multiple head and neck anatomical sites and to assess how these changes affect diagnostic separability between cancerous and noncancerous tissue.
APPROACH: A custom fiber-based, point-scanning FLIm system with phasor-based analysis was used to characterize fluorescence lifetime features in vivo and ex vivo across oral tongue, base of the tongue, and palatine tonsil tissue from 75 patients undergoing oropharyngeal surgery. A separability index based on phasor distributions was used to quantify cancer versus noncancer contrast across multiple spectral channels.
RESULTS: Resection-induced changes in decay dynamics and fluorescence lifetime values varied by anatomy: oral tongue and tonsil showed reduced contrast ex vivo, whereas the base of tongue demonstrated improved separation after excision. The base of the tongue showed a higher separability index ex vivo (0.43 versus 0.15 in vivo), whereas oral tongue and tonsil maintained superior contrast in vivo (0.27 versus 0.18 and 0.46 versus 0.28, respectively).
CONCLUSIONS: Surgical resection substantially alters autofluorescence signatures in an anatomy-dependent manner, emphasizing the need to train and validate diagnostic algorithms independently for in vivo surgical guidance and ex vivo pathology assessment.